DSA

Kardiyovasküler Sağlık İçin En İyi Bileşikler

Kalp sağlığı, kan basıncı ve damar fonksiyonu için çalışılan bileşikler.

16 bileşik etkinliğe göre sıralandı

01

VIP

Extensively Studied

Vasoactive Intestinal Peptide | Neuropeptide

Yarı ömür: 1-2 minutes

02

Sildenafil

FDA Approved

PDE5 Inhibitor | Erectile Function & Pulmonary Hypertension

Yarı ömür: ~3-5 hours

03

Tadalafil

FDA Approved

PDE5 Inhibitor | Erectile Function & Blood Flow

Yarı ömür: ~17.5 hours

04

Retatrutide

Extensively Studied

Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes

Yarı ömür: ~6 days

05

Tirzepatide

FDA Approved

Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes

Yarı ömür: ~5 days (120 hours)

06

SS-31

Well Studied

Mitochondrial-Targeted Peptide | Cardiolipin Protector

Yarı ömür: ~2 hours

07

Hexarelin

Well Studied

Examorelin | Synthetic Growth Hormone Secretagogue

Yarı ömür: 1-2 hours

08

Mazdutide

Extensively Studied

Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes

Yarı ömür: 6-8 days

09

B7-33

Emerging

Relaxin-2 Analog | Anti-Fibrotic & Cardiovascular

Yarı ömür: Not well characterized

10

Cardiogen

Moderate Research

AEDR | Cardiovascular Bioregulator Peptide

Yarı ömür: Minutes (short peptide); effects persist via epigenetic changes

11

Vesugen

Moderate Research

KED | Vascular Bioregulator Peptide

Yarı ömür: Not established

12

Thymosin Beta-4

Well Studied

43-Amino Acid Regenerative Peptide | Tissue Repair & Healing

Yarı ömür: Dose-dependent; relatively short (exact values not established)

13

TB-500 (Ac-LKKTETQ)

Moderate Research

Thymosin Beta-4 Active Fragment | Healing Peptide

Yarı ömür: Not precisely established; effects persist longer than 24 hours

14

NMN

Moderate Research

NAD+ Precursor | Cellular Energy & Longevity

Yarı ömür: ~2-3 hours (oral)

15

AICAR

limited

5-Aminoimidazole-4-carboxamide Ribonucleotide | AMPK Activator

Yarı ömür: ~2-3 hours

16

SLU-PP-332

Emerging

Synthetic Pan-ERR Agonist | Exercise Mimetic & Metabolic Modulator

Yarı ömür: Under investigation (no human PK data)

Diğer hedefler